Search Results - "Quartuccio, Luca"

Refine Results
  1. 1

    COVID 19: a clue from innate immunity by Birra, Domenico, Benucci, Maurizio, Landolfi, Luigi, Merchionda, Anna, Loi, Gabriella, Amato, Patrizia, Licata, Gaetano, Quartuccio, Luca, Triggiani, Massimo, Moscato, Paolo

    Published in Immunologic research (01-06-2020)
    “…The recent COVID-19 pandemic has had a significant impact on our lives and has rapidly expanded to reach more than 4 million cases worldwide by May 2020. These…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases by Quartuccio, Luca, Treppo, Elena, Valent, Francesca, De Vita, Salvatore

    Published in Internal and emergency medicine (01-04-2021)
    “…ANCA-associated vasculitides (AAV) comprise a group of systemic vasculitides characterized by inflammation of small-sized blood vessels leading to multi-organ…”
    Get full text
    Journal Article
  4. 4

    Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature by Colatutto, Donatella, Sonaglia, Arianna, Zabotti, Alen, Cereser, Lorenzo, Girometti, Rossano, Quartuccio, Luca

    Published in Viruses (06-08-2021)
    “…Severe acute respiratory coronavirus-2 syndrome (SARS-CoV-2) is a well-known pandemic infectious disease caused by an RNA virus belonging to the coronaviridae…”
    Get full text
    Journal Article
  5. 5

    A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy by Mazzaro, Cesare, Quartuccio, Luca, Adinolfi, Luigi Elio, Roccatello, Dario, Pozzato, Gabriele, Nevola, Riccardo, Tonizzo, Maurizio, Gitto, Stefano, Andreone, Pietro, Gattei, Valter

    Published in Viruses (09-11-2021)
    “…Extrahepatic manifestations are a feature of chronic hepatitis C virus (HCV) infection. In the course of chronic HCV infection, about 70% of patients have one…”
    Get full text
    Journal Article
  6. 6

    Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients by Retamozo, Soledad, Gheitasi, Hoda, Quartuccio, Luca, Kostov, Belchin, Corazza, Laura, Bové, Albert, Sisó-Almirall, Antoni, Gandía, Myriam, Ramos-Casals, Manuel, De Vita, Salvatore, Brito-Zerón, Pilar

    Published in Rheumatology (Oxford, England) (01-08-2016)
    “…To evaluate the fulfilment of classification criteria for cryoglobulinaemic vasculitis (CV) at diagnosis in a large cohort of patients with primary SS and…”
    Get full text
    Journal Article
  7. 7

    A comparative study of different antiviral treatment protocols in HCV related cryoglobulinemic vasculitis by Allam, Walaa Ramadan, Hegazy, Mohamed Tharwat, Hussein, Mohamed A., Zoheir, Naguib, Quartuccio, Luca, El-Khamisy, Sherif F., Ragab, Gaafar

    Published in Scientific reports (23-05-2024)
    “…The treatment of HCV and its sequelae are used to be predominantly based on Interferon (IFN). However, this was associated with significant adverse events as a…”
    Get full text
    Journal Article
  8. 8

    Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data by Quartuccio, Luca, Zabotti, Alen, Del Zotto, Stefania, Zanier, Loris, De Vita, Salvatore, Valent, Francesca

    Published in Journal of advanced research (01-01-2019)
    “…[Display omitted] •In this cohort, adalimumab and etanercept are the most commonly prescribed biologics.•Risk of hospitalized infections increases under…”
    Get full text
    Journal Article
  9. 9

    Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives by Quartuccio, Luca, Treppo, Elena, Urso, Livio, Del Frate, Giulia, Mescia, Federica, Alberici, Federico, Vaglio, Augusto, Emmi, Giacomo

    Published in Frontiers in immunology (23-02-2023)
    “…In recent years, clinical research has increased significantly and therapies for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have…”
    Get full text
    Journal Article
  10. 10

    Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review by Depascale, Roberto, Del Frate, Giulia, Gasparotto, Michela, Manfrè, Valeria, Gatto, Mariele, Iaccarino, Luca, Quartuccio, Luca, De Vita, Salvatore, Doria, Andrea

    “…Lung involvement in systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS) has extensively been outlined with a multiplicity of different…”
    Get full text
    Book Review Journal Article
  11. 11

    Sjögren syndrome: looking forward to the future by Zandonella Callegher, Sara, Giovannini, Ivan, Zenz, Sabine, Manfrè, Valeria, Stradner, Martin H., Hocevar, Alojzija, Gutierrez, Marwin, Quartuccio, Luca, De Vita, Salvatore, Zabotti, Alen

    “…Primary Sjögren’s syndrome (pSS) is a heterogeneous disease characterised by a wide spectrum of manifestations that vary according to the different stages of…”
    Get full text
    Book Review Journal Article
  12. 12

    Sonographic Appearance of Lacrimal Glands in Sjögren's Syndrome at High Risk for Lymphoma Development by Giovannini, Ivan, Pegolo, Enrico, Longhino, Simone, Quartuccio, Luca, Zabotti, Alen

    Published in Curēus (Palo Alto, CA) (06-12-2023)
    “…Primary Sjögren's syndrome (pSS) is an autoimmune systemic disease characterized by the destruction of exocrine glands, mainly salivary and lacrimal glands…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak by Sonaglia, Arianna, Comoretto, Rosanna, Pasut, Enrico, Treppo, Elena, Del Frate, Giulia, Colatutto, Donatella, Zabotti, Alen, De Vita, Salvatore, Quartuccio, Luca

    Published in Viruses (01-07-2022)
    “…This study aims to explore disease patterns of coronavirus disease (COVID-19) in patients with rheumatic musculoskeletal disorders (RMD) treated with…”
    Get full text
    Journal Article
  20. 20